CN109721529B - Simple preparation method of 2, 5-dichloropyridine - Google Patents

Simple preparation method of 2, 5-dichloropyridine Download PDF

Info

Publication number
CN109721529B
CN109721529B CN201711020260.5A CN201711020260A CN109721529B CN 109721529 B CN109721529 B CN 109721529B CN 201711020260 A CN201711020260 A CN 201711020260A CN 109721529 B CN109721529 B CN 109721529B
Authority
CN
China
Prior art keywords
dichloropyridine
mass
reaction
diester
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201711020260.5A
Other languages
Chinese (zh)
Other versions
CN109721529A (en
Inventor
戚聿新
吕强三
李艳平
鞠立柱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinfa Pharmaceutical Co Ltd
Original Assignee
Xinfa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xinfa Pharmaceutical Co Ltd filed Critical Xinfa Pharmaceutical Co Ltd
Priority to CN201711020260.5A priority Critical patent/CN109721529B/en
Publication of CN109721529A publication Critical patent/CN109721529A/en
Application granted granted Critical
Publication of CN109721529B publication Critical patent/CN109721529B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention provides a green, safe, simple and convenient preparation method of 2, 5-dichloropyridine. The invention takes maleic diester as an initial raw material, and prepares 2, 5-dichloropyridine by condensation with nitromethane, hydrogenation cyclization and chlorination. The preparation method is simple, easy to operate, high in reaction selectivity, high in product yield and purity; the method has the advantages of less waste water generation amount, environmental protection and high reaction safety; and the used raw materials are cheap and easy to obtain, and the cost is low.

Description

Simple preparation method of 2, 5-dichloropyridine
Technical Field
The invention relates to a simple preparation method of 2, 5-dichloropyridine, belonging to the technical field of medical chemistry.
Background
2, 5-dichloropyridine is an important pesticide and a medicine intermediate, can be used for synthesizing medicine intermediates of anti-AIDS, anti-peptic ulcer and the like, can also be used as an intermediate of pyridine insecticides, and has wide application in the fields of dyes, medicines, pesticides and the like.
The 2, 5-dichloropyridine mainly comprises the following three synthesis methods, and is prepared by respectively taking 2-chloropyridine, 2-aminopyridine and 2,3, 6-trichloropyridine as starting materials.
1.2, 5-dichloropyridine and 2, 3-dichloropyridine were prepared by reacting 2-chloropyridine as a starting material with n-butanol to give 2-butoxypyridine, introducing chlorine gas to give a mixture of 85 wt% of 2-butoxy-5-chloropyridine and 15 wt% of 2-butoxy-3-chloropyridine, and then chlorinating with phosphorus oxychloride, and the mixture was separated with an aqueous isopropanol solution to give 2, 5-dichloropyridine in a total yield of 36.29%, as illustrated in scheme 1 below (see patent document US 5380862):
Figure BDA0001447303770000011
the method in the synthetic route 1 has the advantages of multiple steps, long period, complex treatment, large toxicity of the used raw material chlorine, no contribution to safety and environmental protection, poor reaction selectivity, large separation difficulty, low total yield and difficult realization of industrialization, and the mixture of the 2, 5-dichloropyridine and the 2, 3-dichloropyridine needs to be separated.
2. 2-aminopyridine is taken as a raw material, 2-aminopyridine is dissolved in concentrated hydrochloric acid and hydrogen peroxide for chlorination to generate an intermediate product 2-amino-5-chloropyridine, and then diazotization and sandmeyer reaction are carried out to obtain a target product 2, 5-dichloropyridine with the total yield of 58 percent, which is described as the following synthetic route 2 (see the document: the master paper of Harbin university of science and technology, 2012, the synthesis of dichloropyridine, Wang Hui Juan):
Figure BDA0001447303770000012
Figure BDA0001447303770000021
the diazonium salt generated by the diazotization reaction in the synthetic route 2 is easy to decompose at a slightly high temperature or under the action of light, the diazonium salt is unstable, high in activity, and can be decomposed and exploded by heating or friction and impact, so that the method is not beneficial to safety and environmental protection, and the yield of the target product 2, 5-dichloropyridine is low, so that the method is not suitable for industrial development.
3. Using 2,3, 6-trichloropyridine as a raw material, dissolving 2,3, 6-trichloropyridine in benzene or toluene, adding a sodium hydroxide solution, heating to reflux, adding zinc powder in three batches for reduction reaction, cooling and filtering to obtain a crude product of 2, 5-dichloropyridine, and then recrystallizing with ethanol to obtain 2, 5-dichloropyridine with a total yield of 78.3%, which is described as the following synthetic route 3 (see patent document CN 101709050A):
Figure BDA0001447303770000022
the raw material 2,3, 6-trichloropyridine used in the method of the synthesis route 3 is expensive, a solvent with high toxicity of benzene and toluene is used, zinc powder is added in batches, the operation is inconvenient, a crude product needs to be recrystallized and refined, a large amount of ethanol solvent is needed, and a large amount of solid waste is generated, so that the method is not safe and environment-friendly.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides a green, safe, simple and convenient preparation method of 2, 5-dichloropyridine. The preparation method is simple, easy to operate, high in reaction selectivity, high in product yield and purity; the method has the advantages of less waste water generation amount, environmental protection and high reaction safety; and the used raw materials are cheap and easy to obtain, and the cost is low.
Description of terms:
maleic acid diester: also known as maleic diesters;
a compound of formula II: cis-5-nitro-4-oxo-2-pentenoate;
a compound of formula III: 2, 5-dihydroxypyridine, also known as 5-hydroxypyridin-2 (1H) -one.
The technical scheme of the invention is as follows:
a preparation method of 2, 5-dichloropyridine comprises the following steps:
(1) carrying out condensation reaction on maleic diester and nitromethane under the catalysis of organic base to prepare reaction liquid containing a compound shown in a formula II; adding a solvent and a catalyst into the reaction solution without separating, and carrying out hydrogenation cyclization on the compound of the formula II in the reaction solution to prepare a compound of a formula III;
wherein R in the compound of the formula II is one of C1-4 alkyl; preferably, R is one of methyl, ethyl, isopropyl or tert-butyl;
Figure BDA0001447303770000031
(2) and (3) chlorinating the compound shown in the formula III and a chlorinating reagent to prepare the 2, 5-dichloropyridine.
According to the invention, the mole ratio of the maleic acid diester and the nitromethane in the step (1) is preferably 1 (0.90-1.1).
Preferably, in step (1), the maleic acid diester is one of dimethyl maleate, diethyl maleate, diisopropyl maleate or di-tert-butyl maleate.
Preferably according to the invention, the organic base in step (1) is one or a combination of two of 1, 8-diazabicyclo [5.4.0] -7-undecene (DBU) or 1, 5-diazabicyclo [4.3.0] -5-nonene (DBN).
According to the invention, the mass of the organic base in the step (1) is preferably 1.2-5% of that of the maleic acid diester; preferably, the mass of the organic base in step (1) is 1.5-4% of the mass of the maleic acid diester.
According to the invention, the condensation reaction temperature in the step (1) is preferably 30-90 ℃; preferably, the condensation reaction temperature in step (1) is 60-70 ℃. The reaction time is 2-8 hours.
According to the invention, the mass of the catalyst in the step (1) is preferably 0.5-15% of that of the maleic acid diester.
Preferably according to the invention, the catalyst in step (1) is palladium on carbon or Raney nickel.
Preferably, the mass of the palladium carbon is 0.5-5% of that of the maleic diester; more preferably, the mass of the palladium-carbon is 1 to 3 percent of that of the maleic acid diester.
Preferably, the mass of the raney nickel is 1 to 15% of the mass of the maleic acid diester, and more preferably, the mass of the raney nickel is 5 to 10% of the mass of the maleic acid diester. The type and amount of the catalyst are important for improving the yield of the 2, 5-dihydroxypyridine.
According to the present invention, the solvent in step (1) is one or a mixture of two or more of methanol, ethanol, isopropanol, tetrahydrofuran, dichloromethane, 1, 2-dichloroethane, or toluene.
According to the invention, the mass ratio of the maleic acid diester to the solvent in the step (1) is preferably 1 (3-15).
Preferably, according to the invention, in the step (1) of the hydrocyclization reaction, the hydrogen pressure is 0.1-0.3 MPa; the temperature of the hydrogenation cyclization reaction in the step (1) is 20-80 ℃; preferably, the temperature of the hydrogenation cyclization reaction in the step (1) is 50-70 ℃. The reaction time is 3-8 hours.
According to the invention, the chlorinating reagent in the step (2) is one or the combination of more than two of thionyl chloride, phosphorus oxychloride or phosphorus pentachloride.
According to the invention, the molar ratio of the compound shown in the formula III and the chlorinated reagent in the step (2) is 1 (5-15).
According to the invention, the chlorination reaction temperature in the step (2) is preferably 40-160 ℃; preferably, the chlorination reaction temperature in the step (2) is 60-150 ℃. The reaction time is 2-18 hours.
The process of the present invention is depicted as scheme 4 below:
Figure BDA0001447303770000041
the invention has the technical characteristics and beneficial effects that:
1. the invention uses maleic diester and nitromethane to carry out condensation reaction under the catalysis of organic base to prepare cis-5-nitryl-4-oxo-2-n-pentenoic acid ester (II), then prepares 2, 5-dihydroxypyridine (III) through hydrogenation cyclization, and then prepares 2, 5-dichloropyridine (I) through chlorination with a chlorination reagent.
2. The designed unit reaction has high safety, does not relate to low-temperature chlorination reaction or diazotization reaction with large potential safety hazard, does not use toxic gases such as chlorine gas with large toxicity, has high reaction selectivity, is easy to operate, has high product yield and high purity, has the total yield of 88.6 percent, and is suitable for industrial production.
3. The method has the advantages of cheap and easily obtained raw materials, simple and convenient route, simple post-treatment and low cost, and does not need to use a solvent to recrystallize a final product, thereby having less waste water generation amount and being green and environment-friendly.
Detailed Description
The present invention is described in detail below with reference to examples, but the present invention is not limited thereto.
The raw materials and reagents used in the examples are all commercially available products. In the examples, "%" is given by weight unless otherwise specified. The yields in the examples are all molar yields.
Example 1: preparation of 2, 5-dihydroxypyridine
30.5 g (0.5 mol) of nitromethane, 72.0 g (0.5 mol) of dimethyl maleate and 1.8 g of DBU are added into a 500 ml four-neck flask which is connected with a stirring, thermometer and reflux condenser, stirred and reacted at the temperature of 60-65 ℃ for 5 hours, and cooled to 20-25 ℃. Transferring the obtained reaction liquid into a 1-liter autoclave, adding 400 g of methanol and 1.0 g of palladium-carbon (containing 50wt percent of water) catalyst with the palladium mass content of 5 percent, replacing the mixture by nitrogen for three times, introducing hydrogen, keeping the hydrogen pressure at 0.1-0.2MPa, and reacting for 4 hours at 50-55 ℃. After nitrogen replacement for three times, the catalyst is removed by filtration, the filtrate is concentrated and evaporated to dryness, 100 g of methyl tertiary butyl ether is added for recrystallization, 51.7 g of light yellow solid 2, 5-dihydroxypyridine (III) is obtained, the liquid phase purity is 99.7 percent, and the product yield is 93.1 percent.
Example 2: preparation of 2, 5-dihydroxypyridine
30.5 g (0.5 mol) of nitromethane, 86.1 g (0.5 mol) of diethyl maleate and 1.8 g of DBN are added into a 500 ml four-neck flask which is connected with a stirring, thermometer and reflux condenser, stirred and reacted at 65-70 ℃ for 5 hours, and cooled to 20-25 ℃. Transferring the obtained reaction liquid into a 1-liter autoclave, adding 400 g of ethanol and 1.2 g of palladium-carbon (containing 50wt percent of water) catalyst with the palladium mass content of 5 percent, replacing the mixture by nitrogen for three times, introducing hydrogen, keeping the hydrogen pressure at 0.1-0.2MPa, and reacting for 4 hours at 50-55 ℃. After nitrogen replacement for three times, the catalyst is removed by filtration, the filtrate is concentrated and evaporated to dryness, 100 g of methyl tertiary butyl ether is added for recrystallization, 52.2 g of light yellow solid 2, 5-dihydroxypyridine (III) is obtained, the liquid phase purity is 99.8 percent, and the product yield is 94.0 percent.
Example 3: preparation of 2, 5-dihydroxypyridine
30.5 g (0.5 mol) of nitromethane, 100.1 g (0.5 mol) of diisopropyl maleate and 1.8 g of DBU are added into a 500 ml four-neck flask which is connected with a stirring, thermometer and reflux condenser, stirred and reacted at 65-70 ℃ for 5 hours, and cooled to 20-25 ℃. Transferring the obtained reaction liquid into a 1-liter autoclave, adding 400 g of isopropanol and 8.0 g of Raney nickel (containing 50wt percent of water) catalyst with the nickel content of 50 percent by mass, replacing the catalyst with nitrogen for three times, introducing hydrogen, keeping the pressure of the hydrogen at 0.1-0.2MPa, and reacting for 4 hours at the temperature of 60-65 ℃. After nitrogen replacement for three times, the catalyst is removed by filtration, the filtrate is concentrated and evaporated to dryness, 100 g of methyl tertiary butyl ether is added for recrystallization, 52.0 g of light yellow solid 2, 5-dihydroxypyridine (III) is obtained, the liquid phase purity is 99.6 percent, and the product yield is 93.6 percent.
Example 4: preparation of 2, 5-dihydroxypyridine
30.5 g (0.5 mol) of nitromethane, 114.1 g (0.5 mol) of di-tert-butyl maleate and 1.8 g of DBU are added into a 500 ml four-neck flask which is connected with a stirring, thermometer and reflux condenser, stirred and reacted at 65-70 ℃ for 5 hours, and cooled to 20-25 ℃. Transferring the obtained reaction liquid into a 1-liter autoclave, adding 400 g of tetrahydrofuran and 9.0 g of Raney nickel (containing 50wt percent of water) catalyst with the nickel content of 50 percent by mass, replacing the catalyst with nitrogen for three times, introducing hydrogen, keeping the pressure of the hydrogen at 0.1-0.2MPa, and reacting for 5 hours at the temperature of 60-65 ℃. After nitrogen replacement for three times, the catalyst is removed by filtration, the filtrate is concentrated and evaporated to dryness, 100 g of methyl tertiary butyl ether is added for recrystallization, 50.8 g of light yellow solid 2, 5-dihydroxypyridine (III) is obtained, the liquid phase purity is 99.7 percent, and the product yield is 91.5 percent.
Example 5: preparation of 2, 5-dichloropyridine
Into a 500 ml four-necked flask equipped with a thermometer, mechanical stirring, and reflux condenser were charged 150 g of phosphorus oxychloride, 22.0 g (0.2 mol) of 2, 5-dihydroxypyridine prepared in example 2, 105.0 g (0.5 mol) of phosphorus pentachloride, and the mixture was stirred at 70-75 ℃ for reaction for 12 hours, then the excess phosphorus oxychloride was recovered by distillation under reduced pressure, the residue was slowly poured into 300 g of ice water, sufficiently stirred, then neutralized with 40% aqueous sodium hydroxide solution at pH 7-9, extracted three times with dichloromethane, 50 g each, the organic phases were combined, washed with 30 g of saturated common salt, then dried with 5 g of anhydrous sodium sulfate, and the solvent was removed by rotary evaporation to give 27.5 g of 2, 5-dichloropyridine (I) as a pale yellow powder in 92.9% yield with 99.7% liquid phase purity. The nuclear magnetic data of the product are as follows:
1H NMR(CDCl3,,ppm):
7.38(d,1H),7.64(d,1H),8.35(s,1H)。
example 6: preparation of 2, 5-dichloropyridine
To a 500 ml four-necked flask equipped with a thermometer, mechanical stirring, reflux condenser, 200 g of thionyl chloride, 22.0 g (0.2 mol) of 2, 5-dihydroxypyridine prepared in example 2, 105.0 g (0.5 mol) of phosphorus pentachloride, stirred at 60-65 ℃ for reaction for 15 hours, then distilled under reduced pressure to recover the excess thionyl chloride, the residue was slowly poured into 300 g of ice water, sufficiently stirred, then neutralized to pH 7-9 with 40% aqueous sodium hydroxide solution, extracted three times with dichloromethane, 50 g each time, the organic phases were combined, washed with 30 g of saturated brine, then dried with 5 g of anhydrous sodium sulfate, and the solvent was removed by rotary evaporation to obtain 26.8 g of 2, 5-dichloropyridine (I) as a pale yellow powder in 90.5% yield and 99.8% purity of the liquid phase.
Example 7: preparation of 2, 5-dichloropyridine
200 g of phosphorus oxychloride, 22.0 g (0.2 mol) of 2, 5-dihydroxypyridine prepared in example 2, stirring and reacting at 145 ℃ for 4 hours in a 500 ml four-neck flask equipped with a thermometer, a mechanical stirrer and a reflux condenser were added, then the excess phosphorus oxychloride was recovered by distillation under reduced pressure, the residue was slowly poured into 300 g of ice water and stirred well, then neutralized with 40% aqueous sodium hydroxide solution to a pH of 7-9, extracted three times with dichloromethane, 50 g each time, the organic phases were combined, washed with 30 g of saturated brine, then dried with 5 g of anhydrous sodium sulfate, and the solvent was removed by rotary evaporation to give 27.9 g of 2, 5-dichloropyridine (I) as a pale yellow powder with a yield of 94.3% and a liquid phase purity of 99.5%.
Comparative example 1: preparation of 2, 5-dihydroxypyridine
30.5 g (0.5 mol) of nitromethane, 72.0 g (0.5 mol) of dimethyl maleate and 0.8 g of DBU are added into a 500 ml four-neck flask which is connected with a stirring, thermometer and reflux condenser, stirred and reacted for 5 hours at the temperature of 60-65 ℃ and cooled to 20-25 ℃. Transferring the obtained reaction liquid into a 1-liter autoclave, adding 400 g of methanol and 1.0 g of palladium-carbon (containing 50wt percent of water) catalyst with the palladium mass content of 5 percent, replacing the mixture by nitrogen for three times, introducing hydrogen, keeping the hydrogen pressure at 0.1-0.2MPa, and reacting for 4 hours at 50-55 ℃. After nitrogen replacement for three times, the catalyst is removed by filtration, the filtrate is concentrated and evaporated to dryness, 100 g of methyl tertiary butyl ether is added for recrystallization, 31.2 g of light yellow solid 2, 5-dihydroxypyridine (III) is obtained, the liquid phase purity is 99.1 percent, and the product yield is 56.2 percent.
From this comparative example, it can be seen that the use of organic base catalyst was too low and the reaction was not complete, resulting in a lower yield of 2, 5-dihydroxypyridine.
Comparative example 2: preparation of 2, 5-dihydroxypyridine
30.5 g (0.5 mol) of nitromethane, 72.0 g (0.5 mol) of dimethyl maleate and 1.8 g of DBU are added into a 500 ml four-neck flask which is connected with a stirring, thermometer and reflux condenser, stirred and reacted at the temperature of 98-100 ℃ for 3 hours, and cooled to 20-25 ℃. Transferring the obtained reaction liquid into a 1-liter autoclave, adding 400 g of methanol and 1.0 g of palladium-carbon (containing 50wt percent of water) catalyst with the palladium mass content of 5 percent, replacing the mixture by nitrogen for three times, introducing hydrogen, keeping the hydrogen pressure at 0.1-0.2MPa, and reacting for 4 hours at 50-55 ℃. After nitrogen replacement for three times, the catalyst is removed by filtration, the filtrate is concentrated and evaporated to dryness, 100 g of methyl tertiary butyl ether is added for recrystallization, 28.5 g of light yellow solid 2, 5-dihydroxypyridine (III) is obtained, the liquid phase purity is 98.6 percent, and the product yield is 51.4 percent.
From this comparative example, it is clear that the condensation reaction temperature is too high, other by-products are large, and the yield is lowered.
Comparative example 3: preparation of 2, 5-dihydroxypyridine
42.0 g (0.7 mol) of nitromethane, 72.0 g (0.5 mol) of dimethyl maleate and 1.8 g of DBU are added into a 500 ml four-neck flask which is connected with a stirring, thermometer and reflux condenser, stirred and reacted at the temperature of 60-65 ℃ for 5 hours, and cooled to 20-25 ℃. Transferring the obtained oily liquid into a 1-liter autoclave, adding 400 g of methanol and 1.0 g of palladium-carbon (containing 50 wt% of water) catalyst with the palladium mass content of 5%, replacing with nitrogen for three times, introducing hydrogen, keeping the hydrogen pressure at 0.1-0.2MPa, and reacting at 50-55 ℃ for 4 hours. After nitrogen replacement for three times, the catalyst is removed by filtration, the filtrate is concentrated and evaporated to dryness, 100 g of methyl tertiary butyl ether is added for recrystallization, 34.1 g of light yellow solid 2, 5-dihydroxypyridine (III) is obtained, the liquid phase purity is 99.3 percent, and the product yield is 61.5 percent.
From this comparative example, it is seen that an inappropriate ratio of nitromethane to maleic diester results in the condensation of two molecules of nitromethane and 1 molecule of maleic diester with more viscous by-products and a lower yield.

Claims (10)

1. A preparation method of 2, 5-dichloropyridine comprises the following steps:
(1) carrying out condensation reaction on maleic diester and nitromethane under the catalysis of organic base to prepare reaction liquid containing a compound shown in a formula II; adding a solvent and a catalyst into the reaction solution without separating, and carrying out hydrogenation cyclization on the compound of the formula II in the reaction solution to prepare a compound of a formula III; the organic base is one or the combination of two of 1, 8-diazabicyclo [5.4.0] -7-undecene (DBU) or 1, 5-diazabicyclo [4.3.0] -5-nonene (DBN); the catalyst is palladium carbon or Raney nickel;
wherein R in the compound of formula II is C1-4One of the alkyl groups of (a);
Figure FDA0002546633220000011
(2) and (3) chlorinating the compound shown in the formula III and a chlorinating reagent to prepare the 2, 5-dichloropyridine.
2. The method for preparing 2, 5-dichloropyridine according to claim 1, wherein the molar ratio of the maleic diester to the nitromethane in step (1) is 1 (0.90-1.1); in the step (1), the maleic acid diester is one of dimethyl maleate, diethyl maleate, diisopropyl maleate or di-tert-butyl maleate.
3. The method for preparing 2, 5-dichloropyridine according to claim 1, wherein the mass of the organic base in step (1) is 1.2-5% of the mass of the maleic diester.
4. The process for producing 2, 5-dichloropyridine according to claim 1, wherein the condensation reaction temperature in step (1) is from 30 to 90 ℃.
5. The method for preparing 2, 5-dichloropyridine according to claim 1, wherein the mass of the catalyst in step (1) is 0.5-15% of that of the maleic diester.
6. The method for preparing 2, 5-dichloropyridine according to claim 1, wherein the mass of the palladium-carbon in step (1) is 0.5-5% of the mass of the maleic diester; the mass of the Raney nickel is 1-15% of that of the maleic diester.
7. The process for producing 2, 5-dichloropyridine according to claim 1, wherein the solvent in step (1) is one or a mixture of two or more of methanol, ethanol, isopropanol, tetrahydrofuran, dichloromethane, 1, 2-dichloroethane and toluene; in the step (1), the mass ratio of the maleic acid diester to the solvent is 1 (3-15).
8. The process according to claim 1, wherein the hydrogen pressure in the hydrocyclization reaction in the step (1) is 0.1 to 0.3 MPa; the temperature of the hydrogenation cyclization reaction in the step (1) is 20-80 ℃.
9. The process for preparing 2, 5-dichloropyridine according to claim 1, wherein the chlorinating reagent in step (2) is one or a combination of more than two of thionyl chloride, phosphorus oxychloride and phosphorus pentachloride; the molar ratio of the compound shown in the formula III to the chlorinated reagent in the step (2) is 1 (5-15).
10. The process for preparing 2, 5-dichloropyridine according to claim 1, wherein the chlorination reaction temperature in step (2) is 40-160 ℃.
CN201711020260.5A 2017-10-27 2017-10-27 Simple preparation method of 2, 5-dichloropyridine Active CN109721529B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711020260.5A CN109721529B (en) 2017-10-27 2017-10-27 Simple preparation method of 2, 5-dichloropyridine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711020260.5A CN109721529B (en) 2017-10-27 2017-10-27 Simple preparation method of 2, 5-dichloropyridine

Publications (2)

Publication Number Publication Date
CN109721529A CN109721529A (en) 2019-05-07
CN109721529B true CN109721529B (en) 2020-09-01

Family

ID=66290954

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711020260.5A Active CN109721529B (en) 2017-10-27 2017-10-27 Simple preparation method of 2, 5-dichloropyridine

Country Status (1)

Country Link
CN (1) CN109721529B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380862A (en) * 1992-10-07 1995-01-10 Rutgerswerke Aktiengesellschaft Preparation of isomer-free 2,5-dichloro-pyridine
CN101709050A (en) * 2009-11-24 2010-05-19 南京第一农药集团有限公司 New method for synthesizing 2, 5-dichloropyridine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101825544B1 (en) * 2014-10-29 2018-02-05 삼성에스디아이 주식회사 Compound, organic optoelectric device and display device

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380862A (en) * 1992-10-07 1995-01-10 Rutgerswerke Aktiengesellschaft Preparation of isomer-free 2,5-dichloro-pyridine
CN101709050A (en) * 2009-11-24 2010-05-19 南京第一农药集团有限公司 New method for synthesizing 2, 5-dichloropyridine

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
2, 3, 5-三氯吡啶合成的研究;杨祥宇 等;《化学工业与工程》;20040331;第21卷(第2期);第146-148页 *
Ammonium iodide-promoted cyclization of ketones with DMSO and ammonium acetate for synthesis of substituted pyridines;Xiaojun Pan et al.;《RSC Advances》;20150604;第5卷(第63期);第51183–51187页 *
Asymmetric Copper(I)-Catalyzed Henry Reaction with an Aminoindanol-Derived Bisoxazolidine Ligand;Kimberly Yearick Spangler et al.;《Organic Letters》;20091015;第11卷(第20期);第4724-4727页 *
Synthesis of Boc-protected 4,5-methano-β-proline;Andriy V.Tymtsunik et al.;《Tetrahedron Letters》;20140528;第55卷(第22期);第3312-3315页 *

Also Published As

Publication number Publication date
CN109721529A (en) 2019-05-07

Similar Documents

Publication Publication Date Title
EP2185500B1 (en) Method for manufacturing biaryls
WO2015180585A1 (en) Method of producing thiamethoxam
CN110818622B (en) Preparation method of 2, 3-dichloropyridine
CN109942433B (en) A kind of chemical synthesis method of 3', 4', 5'-trifluoro-2-aminobiphenyl
CA2867155C (en) Methods for preparing 3-substituted-6-trifluoromethyl pyridines and methods for using 6-trichloromethyl halogenated pyridines
US4127575A (en) Preparation of chloro substituted pyridines
AU2002213948B2 (en) Process for the preparation of 2-aminoethylpyridines
KR101653025B1 (en) Method for producing 2-amino-4-(trifluoromethyl)pyridine
US6635767B2 (en) Synthesis of heteroarylamine intermediate compounds
EP0385210A2 (en) Amidation of pyridines
CN109721529B (en) Simple preparation method of 2, 5-dichloropyridine
WO2016161826A1 (en) Method for preparing 4-isopropylamino-1-butanol
KR20180116371A (en) Process for producing 4-alkoxy-3-hydroxypicolic acid
JPH01213263A (en) Production of 2-chloro-5-methylpyridine
CN110563726A (en) Preparation method of tert-butyl-7, 9-dioxy-2, 6-diazaspiro [4.5] decane-2-formic acid ester
JPH11124376A (en) Synthesis of organic compound
JP2774170B2 (en) Method for producing 2-amino-4-fluoropyrimidine derivative
CN110483388B (en) Preparation method of nicotinic acid derivative
BR112021014815A2 (en) METHOD FOR PREPARATION OF 4-AMINO-5-METHYLPYRIDONE
EP2835371B1 (en) Industrial method for manufacturing high-purity methiozoline
KR101125531B1 (en) Novel indolizine derivatives and its preparation method
US6822093B2 (en) Synthesis of heteroarylamine intermediate compounds
CN113121435B (en) Synthetic method of 2, 4-dichloroquinoline compound
JP4509327B2 (en) Process for producing N, N-disubstituted-4-aminocrotonic acid ester
IL190807A (en) Process for the preparation of 2-cyanopyridines

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A simple preparation method of 2,5-dichloropyridine

Effective date of registration: 20211130

Granted publication date: 20200901

Pledgee: Zhejiang Commercial Bank Co.,Ltd. Dongying Branch

Pledgor: Xinfa pharmaceutical Co.,Ltd.

Registration number: Y2021980013546